Company intelligence / Profile preview

Shanghai Moyom Biotechnology

Shanghai, Shanghai Shi / Municipality directly under central government, Chinamybiotec.com ↗

Ownership: Private
Development stage: Commercial

Overview

Shanghai Moyom Biotechnology has developed and commercialized Aphranel MagiCCrystal CaHA Filler, the first injectable calcium hydroxylapatite microsphere-based dermal filler approved in China for facial soft tissue augmentation. The product has received NMPA Class III medical device certification, as well as regulatory clearances in the EU, Mexico, Brazil, Russia, and Saudi Arabia. Clinical validation was conducted through multicenter trials with leading Chinese hospitals. The product is fully biodegradable and demonstrates a lower inflammation rate compared to competitors.

Therapeutic areas: Dermatology
Modalities: Device (Injectable dermal filler)Biomaterial-based therapy (Calcium hydroxylapatite microspheres)
Industry: Implantable Medical Devices

Drug pipeline

1 asset

Aphranel MagiCCrystal CaHA

Commercial

Indications: Aesthetic medicine, Facial rejuvenation

Partnerships

Nanjing Tech University (biomaterial technology research)Chinese Academy of SciencesPlastic Surgery Hospital of the Chinese Academy of Medical Sciences (clinical validation)Shanghai Ninth People's Hospital (clinical validation)Joint laboratories with medical aesthetics experts from Germany and Brazil for international adaptation

Beyond the preview

Go deeper on Shanghai Moyom Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Moyom Biotechnology.